Programmed cell death, redox imbalance, and cancer therapeutics.

MLA

Dai, Xiaofeng, et al. “Programmed Cell Death, Redox Imbalance, and Cancer Therapeutics.” Apoptosis, vol. 26, no. 7/8, Aug. 2021, pp. 385–414. EBSCOhost, https://doi.org/10.1007/s10495-021-01682-0.

APA

Dai, X., Wang, D., & Zhang, J. (2021). Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis, 26(7/8), 385–414. https://doi.org/10.1007/s10495-021-01682-0

Chicago

Dai, Xiaofeng, Danjun Wang, and Jianying Zhang. 2021. “Programmed Cell Death, Redox Imbalance, and Cancer Therapeutics.” Apoptosis 26 (7/8): 385–414. doi:10.1007/s10495-021-01682-0.